Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fast-acting insulin aspart and insulin pump settings in adults with type 1 diabetes
2020-001158-23Phase 4Completed
- Sponsor
- Steno Diabetes Center Copenhagen
- Start
- Aug 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of human insulin and insulin aspart in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Steno Diabetes Center Copenhagen. Primary endpoint: CGM-derived time in range 3.9-10.0 mmol/L. Started Aug 2020; status: completed.
02
Drugs
human insulininsulin aspart
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2020-001158-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001158-23.